Gene Symbol | Pearson Correlation Coefficient |
---|---|
CBX4 | 0.752 |
USP19 | 0.722 |
ZNF282 | 0.721 |
ZNF213 | 0.717 |
TAOK2 | 0.712 |
HYOU1 | 0.71 |
PTCD1 | 0.71 |
KAT5 | 0.709 |
ABCF1 | 0.708 |
ARMC6 | 0.705 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.423 |
HBD | -0.402 |
ADH1B | -0.4 |
MTRNR2L6 | -0.396 |
MTRNR2L9 | -0.383 |
MTRNR2L10 | -0.382 |
OR4F29 | -0.38 |
H3F3C | -0.38 |
RSPO1 | -0.374 |
IL18RAP | -0.365 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of CBX8 mRNA" | 18648102 |
D000082 | Acetaminophen | Acetaminophen affects the expression of CBX8 mRNA | 17562736 |
C015001 | arsenite | arsenite results in increased methylation of CBX8 promoter | 23974009 |
C006780 | bisphenol A | bisphenol A results in increased methylation of CBX8 promoter | 27312807 |
C006780 | bisphenol A | bisphenol A affects the expression of CBX8 mRNA | 25181051 |
C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CBX8 mRNA | 28628672 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased methylation of CBX8 promoter | 22457795 |
D004390 | Chlorpyrifos | Chlorpyrifos results in decreased expression of CBX8 mRNA | 20350560 |
D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of CBX8 mRNA | 19549813 |
D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CBX8 mRNA | 28628672 |
C061365 | flusilazole | flusilazole affects the expression of CBX8 mRNA | 21195148 |
C409722 | hexaconazole | hexaconazole affects the expression of CBX8 mRNA | 21195148 |
D017313 | Fenretinide | Fenretinide results in decreased expression of CBX8 mRNA | 28973697 |
D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CBX8 mRNA | 28628672 |
D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CBX8 mRNA | 28628672 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of CBX8 mRNA | 25890327 |
D008694 | Methamphetamine | Methamphetamine results in decreased expression of CBX8 mRNA | 19564919 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CBX8 mRNA | 19710929 |
D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of CBX8 mRNA | 28903501 |
D012822 | Silicon Dioxide | Silicon Dioxide results in decreased expression of CBX8 mRNA | 19073995 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of CBX8 mRNA | 16014739 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CBX8 mRNA | 21570461 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in decreased expression of CBX8 mRNA | 25975270 |
C032910 | triadimefon | triadimefon affects the expression of CBX8 mRNA | 21195148 |
D014635 | Valproic Acid | Valproic Acid results in increased methylation of CBX8 gene | 29154799 |
D014635 | Valproic Acid | Valproic Acid affects the expression of CBX8 mRNA | 17963808 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of CBX8 mRNA | 19136453 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0003727 | single-stranded RNA binding | - | IEA | - |
GO:0005515 | protein binding | - | IPI | 16169070 17332741 18927235 19636380 20543829 20601937 21282530 22094252 23260655 25416956 26496610 27505670 27705803 |
GO:0035064 | methylated histone binding | - | IDA | 21029866 |
GO:0097027 | ubiquitin-protein transferase activator activity | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000122 | negative regulation of transcription by RNA polymerase II | - | IMP | 19636380 21282530 |
GO:0006351 | transcription, DNA-templated | - | IEA | - |
GO:0008284 | positive regulation of cell proliferation | - | IEA | - |
GO:0016574 | histone ubiquitination | - | IEA | - |
GO:0032967 | positive regulation of collagen biosynthetic process | - | IEA | - |
GO:0045739 | positive regulation of DNA repair | - | IEA | - |
GO:0050790 | regulation of catalytic activity | - | IEA | - |
GO:0070301 | cellular response to hydrogen peroxide | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000790 | nuclear chromatin | - | IDA | 19636380 |
GO:0000792 | heterochromatin | - | IEA | - |
GO:0005634 | nucleus | - | IDA | 21282530 |
GO:0005654 | nucleoplasm | - | IDA | - |
GO:0005654 | nucleoplasm | - | TAS | - |
GO:0031519 | PcG protein complex | - | IDA | 21282530 |
GO:0035102 | PRC1 complex | - | IDA | 12167701 19636380 |
KEGG ID | KEGG Term |
---|
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-1257604 | PIP3 activates AKT signaling | TAS |
R-HSA-1257604 | PIP3 activates AKT signaling | IEA |
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-162582 | Signal Transduction | IEA |
R-HSA-212436 | Generic Transcription Pathway | TAS |
R-HSA-2262752 | Cellular responses to stress | TAS |
R-HSA-2559580 | Oxidative Stress Induced Senescence | TAS |
R-HSA-2559583 | Cellular Senescence | TAS |
R-HSA-2990846 | SUMOylation | TAS |
R-HSA-3108214 | SUMOylation of DNA damage response and repair proteins | TAS |
R-HSA-3108232 | SUMO E3 ligases SUMOylate target proteins | TAS |
R-HSA-392499 | Metabolism of proteins | TAS |
R-HSA-4551638 | SUMOylation of chromatin organization proteins | TAS |
R-HSA-4570464 | SUMOylation of RNA binding proteins | TAS |
R-HSA-597592 | Post-translational protein modification | TAS |
R-HSA-6807070 | PTEN Regulation | TAS |
R-HSA-6807070 | PTEN Regulation | IEA |
R-HSA-73857 | RNA Polymerase II Transcription | TAS |
R-HSA-74160 | Gene expression (Transcription) | TAS |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | TAS |
R-HSA-8939243 | RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | TAS |
R-HSA-8943724 | Regulation of PTEN gene transcription | TAS |
R-HSA-8943724 | Regulation of PTEN gene transcription | IEA |
R-HSA-8953897 | Cellular responses to external stimuli | TAS |
R-HSA-9006925 | Intracellular signaling by second messengers | TAS |
R-HSA-9006925 | Intracellular signaling by second messengers | IEA |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
25839328 | Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. (2015 Apr 2) | Zhang L | Am J Hum Genet |